Skip to main content

#162330

Glioblastoma WHO IV spheroid cell line, NCH705

Cat. #162330

Glioblastoma WHO IV spheroid cell line, NCH705

Cat. #: 162330

Organism: Human

Tissue: Brain

£575.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Christel Herold-Mende

Institute: Heidelberg University

Primary Citation: Alhalabi et al. 2022. Neuro Oncol. 24(1):39-51. PMID: 34232320.

Tool Details
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Glioblastoma WHO IV spheroid cell line, NCH705
  • Cancer: Brain
  • Organism: Human
  • Tissue: Brain
  • Growth properties: Mixed - adherent and suspension
  • Description: Glioblastoma WHO IV spheroid cell line, NCH705
  • Biosafety level: 2

Handling

  • Growth medium: serum-free DMEM/F-12: Ham medium, supplemented with 2% B27-admixture (PeloBiotech) and basal fibroblast growth factor (Biomol), epidermal growth factor at 20 ng/ml each, heparin at 5 ng/ml, 1% penicillin/streptomycin
  • Temperature: 37°C
  • Atmosphere: 5% CO2

References

  • Alhalabi et al. 2022. Neuro Oncol. 24(1):39-51. PMID: 34232320.
  • Campos et al. 2014. J Pathol. 234(1):23-33. PMID: 24756862.

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.